Novo Nordisk , maker of the weight-loss drug Wegovy, has been sued in U.S. court by investors claiming the Danish ...

The National Institute for Health and Care Excellence (Nice) is concerned about the number of people regaining weight after ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

I've been paying for Mounjaro for more than a year, and have lost a fair bit of weight. Now it's available on the NHS, will I ...

Experts say NHS patients should be monitored for at least a year after treatment ends, with tailored support provided if ...

FAT jabs are not a “quick fix” and patients must be followed up for at least a year to keep the weight off, the NHS watchdog ...

Noom introduces affordable options for obesity treatments, including Novo Nordisk's Wegovy and GLP-1Rx programs. Read more ...

Patients coming off Wegovy or Mounjaro should have support and advice for at least a year afterwards, NHS told.

Swiss generic drug manufacturer Sandoz plans to launch unbranded weight-loss drugs in Canada at discounts of up to 70% compared to branded versions once patents begin to expire next year, CEO Richard ...

The National Institute for Health and Care Excellence (Nice) issues advice as 1.5 million Brits are using weight loss ...

Health chiefs have raised concerns about people regaining weight after using Wegovy and Mounjaro, saying that patients coming ...

Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.